// App-Quantinova.ai

: Alzheimer’s Disease Genetic Risk Variants Show Brain Cell Type-specific Associations with Protein levels in Cerebrospinal Fluid

Researchers

Presenter

  • Lianne M. Reus

Principal Investigators

  • Sven J Van der lee

  • Charlotte E. Teunissen

  • Johan Gobom

  • Stephanie J. B. Vos

  • Kaj Blennow

  • Henrik Zetterberg

  • Lars Bertram

  • Pieter Jelle Visser

  • Betty M. Tijms

Medical Centers

  • Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University

  • Center for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam university medical center

  • Alzheimer Centre Limburg, MHeNS School for Mental Health and Neuroschience, Maastricht University

  • UK Dementia Research Institute

  • University of Lubeck,

  • Alzheimer Center Amsterdam, Amsterdam UMC

  • Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden

  • Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

Locations

  • Norway

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Mild cognitive impairment

  • Alzheimer's disease

  • Dementia

Biomarkers

  • Nucleoside diphosphate kinase A

  • Chitinase 3 Like 1

  • Tau protein

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved